SCHEMBL24936702

SCHEMBL24936702

CCOC(=O)CCOc1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
TBXAS1 P24557 2/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
LTA4H P09960 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 2/20 0.46
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
CYSLTR2 Q9NS75 1/20 0.46
CYSLTR1 Q9Y271 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7994994 0.92 CYSLTR2 (0.54) TBXAS1KMT2ANPSR1LTA4HL3MBTL1
SCHEMBL38664 0.83 LTA4H (0.60) TDP1LTA4HALDH1A1NPC1POLB
SCHEMBL3951838 0.83 L3MBTL1 (0.66) TDP1KMT2ALTA4HL3MBTL1TSHR
SCHEMBL6638044 0.83 TSHR (0.61) TBXAS1KMT2ANPSR1TSHRALDH1A1
SCHEMBL21992555 0.81 MAPT (0.60) LTA4HALDH1A1LMNAPOLB
SCHEMBL7692039 0.81 LTA4H (0.52) KMT2ANPSR1LTA4HL3MBTL1TSHR
SCHEMBL7692040 0.81 LTA4H (0.52) KMT2ALTA4HL3MBTL1TSHRCYSLTR2
SCHEMBL9127586 0.81 CYSLTR2 (0.51) TBXAS1LTA4HHRH2HRH1CYSLTR2
SCHEMBL9127593 0.81 CYSLTR2 (0.51) TBXAS1LTA4HHRH2HRH1CYSLTR2
SCHEMBL21991849 0.80 MAPT (0.58) KMT2ANPSR1LTA4HL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240245675-A1 PROTEIN SECRETION INHIBITORS GATE BIOSCIENCE, INC. 2024-07-25 US disclosed
EP-4377298-A1 PROTEIN SECRETION INHIBITORS Gate Bioscience, Inc. (US) 2024-06-05 EP disclosed
CN-117999256-A Protein secretion inhibitor 分子门生物科技公司 2024-05-07 CN disclosed
WO-2023010051-A1 PROTEIN SECRETION INHIBITORS GATE BIOSCIENCE, INC. (US) 2023-02-02 WO disclosed
WO-2023010051-A1 PROTEIN SECRETION INHIBITORS GATE BIOSCIENCE, INC. (US) 2023-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240245675-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G TDP1 4073/4885TBXAS1 2907/4885KMT2A 4699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.